Cargando…
Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β
Targeting metalloproteinases has been in the focus of drug design for a long time. However, meprin α and β emerged as potential drug targets just recently and are linked to several diseases with different pathological background. Nevertheless, the validation of meprins as suitable drug targets still...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870012/ https://www.ncbi.nlm.nih.gov/pubmed/36661029 http://dx.doi.org/10.1080/14756366.2023.2165648 |
_version_ | 1784876886235545600 |
---|---|
author | Tan, Kathrin Jäger, Christian Geissler, Stefanie Schlenzig, Dagmar Buchholz, Mirko Ramsbeck, Daniel |
author_facet | Tan, Kathrin Jäger, Christian Geissler, Stefanie Schlenzig, Dagmar Buchholz, Mirko Ramsbeck, Daniel |
author_sort | Tan, Kathrin |
collection | PubMed |
description | Targeting metalloproteinases has been in the focus of drug design for a long time. However, meprin α and β emerged as potential drug targets just recently and are linked to several diseases with different pathological background. Nevertheless, the validation of meprins as suitable drug targets still requires highly potent and selective inhibitors as chemical probes to elucidate their role in pathophysiology. Albeit highly selective inhibitors of meprin β have already been reported, only inhibitors of meprin α with modest activity or selectivity are known. Starting from recently reported heteroaromatic scaffolds, the aim of this study was the optimisation of meprin α and/or meprin β inhibition while keeping the favourable off-target inhibition profile over other metalloproteases. We report potent pan-meprin inhibitors as well as highly active inhibitors of meprin α with superior selectivity over meprin β. The latter are suitable to serve as chemical probes and enable further target validation. |
format | Online Article Text |
id | pubmed-9870012 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-98700122023-01-24 Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β Tan, Kathrin Jäger, Christian Geissler, Stefanie Schlenzig, Dagmar Buchholz, Mirko Ramsbeck, Daniel J Enzyme Inhib Med Chem Research Paper Targeting metalloproteinases has been in the focus of drug design for a long time. However, meprin α and β emerged as potential drug targets just recently and are linked to several diseases with different pathological background. Nevertheless, the validation of meprins as suitable drug targets still requires highly potent and selective inhibitors as chemical probes to elucidate their role in pathophysiology. Albeit highly selective inhibitors of meprin β have already been reported, only inhibitors of meprin α with modest activity or selectivity are known. Starting from recently reported heteroaromatic scaffolds, the aim of this study was the optimisation of meprin α and/or meprin β inhibition while keeping the favourable off-target inhibition profile over other metalloproteases. We report potent pan-meprin inhibitors as well as highly active inhibitors of meprin α with superior selectivity over meprin β. The latter are suitable to serve as chemical probes and enable further target validation. Taylor & Francis 2023-01-20 /pmc/articles/PMC9870012/ /pubmed/36661029 http://dx.doi.org/10.1080/14756366.2023.2165648 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Tan, Kathrin Jäger, Christian Geissler, Stefanie Schlenzig, Dagmar Buchholz, Mirko Ramsbeck, Daniel Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β |
title | Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β |
title_full | Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β |
title_fullStr | Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β |
title_full_unstemmed | Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β |
title_short | Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β |
title_sort | synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870012/ https://www.ncbi.nlm.nih.gov/pubmed/36661029 http://dx.doi.org/10.1080/14756366.2023.2165648 |
work_keys_str_mv | AT tankathrin synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb AT jagerchristian synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb AT geisslerstefanie synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb AT schlenzigdagmar synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb AT buchholzmirko synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb AT ramsbeckdaniel synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb |